Journal profile · ENDOCRINOLOGY & METABOLISM
Diabetologe
ISSN 1860-9716 · eISSN 2731-7455 · Springer Medizin · Berlin Heidelberg · Bimonthly · Founded 2005
Diabetologe: impact factor 0.18; subscription journal; APC about USD 3,090; median 55 days to acceptance (29 articles, last 24 months); community-reported acceptance: easy; 69 articles a year; indexed in Scopus.
Scope
Aims, scope and focus
Diabetologe is published by Springer Medizin. By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Treatment and Management and Diabetes and associated disorders, together about 36.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Zielsetzung der Zeitschrift Die Diabetologie bietet aktuelle Fortbildung für alle diabetologisch tätigen Ärztinnen und Ärzte in Praxis und Klinik: Fachärzt*innen mit abgeschlossener Zusatzausbildung Diabetologie sowie niedergelassene Praktiker*innen, Internist*innen und Allgemeinärzt*innen mit Interessensschwerpunkt Diabetologie. Inhaltlich werden alle Bereiche der angewandten Diabetologie praxisnah abgedeckt. Im Vordergrund stehen Prävention, diagnostische Vorgehensweisen und Komplikationsmanagement sowie gesicherte Therapiestrategien. In jeder Ausgabe vertieft ein Schwerpunktthema einen Teilbereich der Diabetologie. In Übersichtsarbeiten stellen anerkannte Autorinnen und Autoren den aktuellen Stand der Entwicklung dar. Ebenfalls Bestandteil sind die Praxisleitlinien der Deutschen Diabetes Gesellschaft. In der Rubrik „Journal Club" wird richtungsweisende internationale Literatur zusammengefasst und kommentiert. Der zertifizierte Fortbildungsbeitrag mit der Möglichkeit CME-Punkte zu erwerben, ist fester Bestandteil jeder Ausgabe. Ergänzt wird das inhaltliche Spektrum durch die Mitteilungen der Gesellschaften. Die Rubrik „News & Views" veröffentlicht regelmäßig neue Produktinformationen aus der Industrie. Aims & Scope Die Diabetologie offers current training for all diabetologists working in practical and clinical environments: Medical Specialists with completed additional training in diabetology as well as practitioners in private practice, internists and general practitioners with an interest in diabetology. All areas of applied diabetology are covered in a practice-oriented manner. The focus is on prevention, diagnostic procedures and complication management as well as proven therapeutic strategies. Each issue focuses on a specific area of diabetology. In reviews, recognized authors present the current state of development. The practice guidelines of the German Diabetes Society are also included. In the rubric "Journal Club", trend-setting international literature is summarized and commented on. A review article in the rubric “Continuing Medical Education” offers the possibility of earning CME points and is an integral part of every issue. The spectrum of content is supplemented by the societies' news pages. The rubric "News & Views" regularly publishes new product information from the industry. Review All articles of Die Diabetologie are reviewed.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Jochen SeufertPublisher website
Editorial board by country: none in mainland China; most named Germany 33, Austria 2, Switzerland 1 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine13.5%
- Diabetes Treatment and ManagementMedicine12.8%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology10.4%
- Medical and Health Sciences ResearchMedicine9.1%
- Diet and metabolism studiesMedicine8.8%
- Health and Medical StudiesHealth Professions6.8%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology4.4%
- Medical Practices and RehabilitationHealth Professions3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.18LetPub ·
- Impact factor (publisher) 2025
- 0.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.2Publisher website ·
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.07LetPub ·
- h-index
- 7LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 29OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 1.69%LetPub ·
Volume
- Articles per year
- 69LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 144,600Publisher website ·
Articles by year OpenAlex count · 2,030 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 43 | 7 | 23 |
| 2021 | 136 | 30 | 147 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
55 daysMedian, submission to acceptance · P25–P75 13 days – 105 days
- Acceptance to online
- median 32 days (85 articles)
- Submission to online
- median 119 days
- Sample
- 29 articles with submission and acceptance dates (271 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 2,590 / GBP 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePublication ethics, Open access
- Publication ethics
No simultaneous submission to multiple journals Model summary
Ein Manuskript darf nicht gleichzeitig bei mehr als einer Zeitschrift zur Begutachtung eingereicht werden.
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Die Diabetologie, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Medizin
- Country or region
- Berlin Heidelberg
- Language
- German
- Frequency
- Bimonthly
- Founded
- 2005
- ISSN
- 1860-9716
- Print ISSN
- 2731-7447
- Electronic ISSN
- 2731-7455
- Latest issue on the website
- Volume 22, Issue 6 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Diabetologe
What is the impact factor of Diabetologe?
The latest impact factor listed by LetPub is 0.18; CiteScore 0.4, h-index 14.
How long does peer review take at Diabetologe?
Based on the dates recorded on 29 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 13–105 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Diabetologe based?
Of the 36 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (33), Austria (2) and Switzerland (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetologe?
According to LetPub and DOAJ records, Diabetologe is indexed in Scopus. The journal's website also lists SCIE and Embase; that list has not been checked against each database.
Is Diabetologe open access, and what is the APC?
Diabetologe is a subscription journal. APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .